Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock? [Investor's Business Daily]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Investors Business Daily
Related news 8:00 AM ET Shares of Amgen are on an upswing after the company won a patent battle over its drug Enbrel against Novartis... The No. 1 Rated Pharmaceutical Company Just Named A New CEO Here Are 3 Notable Pharma Stocks That Could Top Third-Quarter Estimates BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It? AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It? JNJ Stock Gets A Boost After Settling Opioid Cases — But Should You Buy It? Pfizer Stock Is A Top Pharma Company — But Should You Buy It? Biogen Stock Flailed On Alzheimer's Flop — Is This Biotech Stock A Buy Now? Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Merck stock is on an upswing with a 10% gain in the first nine months of 2019 — outperforming a single-digit dip for the broader group of pharmaceutical companies. The future of Dow Jones pharmaceutical company Merck ( MRK ) is intricately tied to cancer treat
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- WebMD Health Services Announces Employee Engagement Solution Returns to Its Iconic Brand Name, TINYpulse [Yahoo! Finance]Yahoo! Finance
- How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together [Yahoo! Finance]Yahoo! Finance
- Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025 [Yahoo! Finance]Yahoo! Finance
- Merck's Future Brightens With Winrevair's Blockbuster Potential [Seeking Alpha]Seeking Alpha
- Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position [Financial Post (Toronto, Ontario, Canada)]Financial Post
MRK
Earnings
- 2/1/24 - Beat
MRK
Sec Filings
- 3/19/24 - Form S-3ASR
- 3/19/24 - Form S-3ASR
- 2/26/24 - Form 10-K
- MRK's page on the SEC website